Funding

California-Based Shape Memory Medical Secures $10 Million Financing

Aug 24, 2026 | By Devin Jacobs

SUMMARY

Shape Memory Medical secured $10M in financing.
The funding will support clinical trials and product development.
Shape Memory Medical develops vascular treatment devices.

Shape Memory Medical, developer of proprietary shape memory polymer technology for endovascular embolization, has secured $10 million in convertible note financing led by August Global Partners (AGP) with participation from Taiwania Capital.

The company plans to use the capital to support clinical development of its aortic portfolio, including patient follow-up and data collection for the AAA-SHAPE Pivotal Trial and advancement of the FLAGSHIP feasibility trial.

Funding Snapshot

Metric	Details
Fundraise Amount	$10 million
Funding Type	Convertible Note Financing
Valuation	Not disclosed
Company	Shape Memory Medical
Sector	Medical Devices / Healthcare
Headquarters	California, USA

RECOMMENDED FOR YOU

Funding

Mercury Raises $200M Series D Funding, at $5.2B Valuation

Devin Jacobs

May 21, 2026

Funding

[Funding News] HubiFi Raises $2.5 Million Seed Funding Round

Team SR

Aug 7, 2024

Funding

Funding Wrap of the Week | American Startups Funding Roundup | April 7 – April 12

Devin Jacobs

Apr 13, 2024

About Shape Memory Medical

Shape Memory Medical is a medical device company developing therapies based on proprietary shape memory polymer technology.

Its platform uses a low-density, highly porous embolic material that can be delivered through a catheter in a compressed form. Once it comes into contact with blood, the material self-expands and is designed to adapt to complex vascular anatomy.

The company's technology is also bioresorbable and radiolucent, supporting imaging during patient follow-up.

Core offerings include:

Shape memory polymer embolization technology
Endovascular embolization devices
Aortic disease treatment solutions
Bioresorbable vascular technologies

Core Technologies / Products / Services

Capability/Product	Application/Use Case
Shape Memory Polymer	Enables compressed delivery and self-expansion inside blood vessels
IMPEDE-FX RapidFill® Device	Used alongside EVAR to manage the abdominal aortic aneurysm sac
False Lumen Embolization System	Investigational technology for treating aortic dissection false lumen

Leadership Comments

"This financing strengthens our position as we enter a potentially transformative period for the company," said Ted Ruppel, President and Chief Executive Officer of Shape Memory Medical. "With enrollment recently completed in our AAA-SHAPE Pivotal Trial and continued progress in FLAGSHIP, we are focused on generating the clinical evidence needed to support the broader adoption of our shape memory polymer technology in aortic applications.

“For decades, clinicians treating aortic aneurysms and dissections have relied on materials repurposed from other procedures, never engineered for the job. Shape Memory Medical set out to change that with a shape memory polymer platform engineered for embolization, designed to work alongside the stent graft and address a clear unmet clinical need,” said Davian Sim, Partner at August Global Partners.